Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BGLC · Mar 31, 2023
BioNexus Gene Lab Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001477932-23-003193General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-4.98% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-21.52% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
37.84% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
15.52% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-2.13% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Sep 30, 20214/6 normalizedLevel 3Dec 31, 20214/6 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20225/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedAmended as filedDec 31, 20236/6 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/9 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.50%
- Current
- 0.00%
- Delta
- -0.49%
- Previous
- 4.98%
- Current
- -4.98%
- Delta
- -9.95%
- Previous
- -18.21%
- Current
- -21.52%
- Delta
- -3.30%
- Previous
- 8.95%
- Current
- 37.84%
- Delta
- 28.90%
- Previous
- 11.52%
- Current
- 15.52%
- Delta
- 4.00%
- Previous
- -2.66%
- Current
- -2.13%
- Delta
- 0.53%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BGLC Fundamental State →Analogous To · BGLC state analogue 4 →Transitioned To · BGLC PROFITABILITY_INCREASED →Transitioned To · BGLC Fundamental State →Transitioned To · BGLC CAPEX_INTENSITY_DECREASED →Transitioned To · BGLC CASH_GENERATION_DECREASED →Transitioned To · BGLC GROWTH_DECREASED →Transitioned To · BGLC INVENTORY_PRESSURE_INCREASED →Transitioned To · BGLC MARGIN_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.